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Abstract 
The objective of this study was to investigate the efficacy of active immunization against 
gonadotropin releasing hormone (GnRH) in male pigs and to compare it with surgical castration. 
Piglets were randomly assigned to two groups, one of 263 animals for surgical castration (SC) 
and one of 270 animals for immunocastration (IC). Surgery was done at 14 days of age and 
vaccination (Improvac®, CSL, Australia) performed twice at an interval of 4 to 5 weeks with the 
second injection given 4 to 7 weeks before slaughter. At slaughter, testes were weighed and fat 
samples collected for androstenone analysis. Androstenone was tested olfactorially by heating 
salivary glands in a microwave oven. Daily growth rate and meat quality were assessed in all 
animals. Regarding mean androstenone concentrations in backfat, no significant difference was 
found between SC and IC (0.042 (0.041; 0.044) µg/g vs. 0.058 (0.044; 0.071) µg/g; mean (95 % 
confidence interval)). Testes weight was significantly (P<0.001) smaller in immunized (230.8 
(218.23; 243.52) g) as compared to normal boars (761.8 (722.77; 801.01) g) of the same age, as a 
reference. In this study, androstenone production was suppressed in all vaccinated animals and 
the carcasses given free for consumption. Mean daily growth gain was not significantly different 
between SC (0.817 (0.804; 0.830) kg) and IC (0.827 (0.814; 0.840) kg), although there was a 
trend for better performance in the latter group. The yield of lean meat was significantly 
(P<0.001) improved in IC (54.50 (54.26; 54.73) %) when compared to SC (53.76 (53.53; 54.00) 
%). From our results, we conclude that vaccination against GnRH is a practical and effective 
method to suppress androstenone synthesis. Pain and stress associated with surgical castration 
can thus be avoided.  
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Auswirkungen einer aktiven Immunisierung gegen GnRH auf die 
Androstenon-Konzentration, Gewichtszunahme und Schlachtkörperqualität 
beim männlichen Schwein 
 
Zusammenfassung 
Das Ziel dieser Studie war, die Wirkung der aktiven Immunisierung gegen das Gonadotropin 
Releasing Hormon (GnRH) bei männlichen Schweinen zu untersuchen und mit der chirurgischen 
Kastration zu vergleichen. Ferkel wurden randomisiert und in zwei Gruppen unterteilt: 263 Tiere 
für die chirurgische Kastration (SC) und 270 für die Immunokastration (IC). Der chirurgische 
Eingriff wurde in den ersten 14 Lebenstagen durchgeführt und die Impfung mit Improvac®, CSL, 
Australia, zweimal im Abstand von 4 bis 5 Wochen; die zweite Impfung (Booster) erfolgte 4 bis 
7 Wochen vor dem geplanten Schlachttermin. Bei der Schlachtung wurde das Hodengewicht 
gewogen und Fettproben für die Bestimmung von Androstenon gesammelt. Zusätzlich wurde 
Androstenon auch olfaktorisch nach Erhitzung der Speicheldrüsen im Mikrowellenofen getestet. 
Weiter wurden die Tageszuwachsrate und Fleischqualität aller Tiere bestimmt. Die 
durchschnittliche Androstenon- Konzentration im Rückenfett beider Gruppen (SC und IC) wies 
keine signifikanten Unterschiede auf (0.042 (0.041; 0.044) µg/g vs. 0.058 (0.044; 0.071) µg/g; 
Durchschnitt (95 % Konfidenzinterval). Das Hodengewicht von immunisierten Ebern war 
signifikant (P<0.001) kleiner (230.8 (218.23; 243.52) g) als bei normalen Ebern gleichen Alters 
(761.8 (722.77; 801.01) g). In dieser Studie konnte bewiesen werden, dass die Androstenon 
Produktion in allen geimpften Tieren deutlich gehemmt war und alle Schlachtkörper 
konsumtauglich waren.  Der durchschnittliche Tageszuwachs war zwischen SC (0.817 (0.804; 
0.830) kg) und IC (0.827 (0.814; 0.840) kg) nicht signifikant verschieden, obwohl letztere 
Gruppe eine bessere Zuwachsrate zeigte. Der Magerfleischanteil war bei IC (54.50 (54.26; 
54.73) %) im Vergleich zu SC (53.76 (53.53; 54.00) %) signifikant (P<0.001) erhöht. Aus 
unseren Ergebnissen kann gefolgert werden, dass die Impfung gegen GnRH eine praktische und 
effiziente Methode ist, um die Androstenon Synthese erfolgreich zu unterdruecken. Angst und 
Stress, die vor allem bei der chirurgischen Kastration auftreten, können auf diese Weise 
vermieden werden. 
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1. Introduction 
Consumption of pig meat in Switzerland has continuously increased over the last years 
(Statistische Erhebungen und Schätzungen, 2003, Schweiz. Bauernverband, Brugg). This 
development is mainly the result of improved meat quality while keeping the production costs at 
a low level. Besides lean carcass production, the consumers also demand pork which is free of 
distinct boar taint. This unpleasant urine-like odour is mainly caused by androstenone, a 
testicular steroid that accumulates in fat tissue (Patterson, 1968). Another contributor of boar 
taint is skatole, but contrary to androstenone, this substance is not entirely male-specific being a 
product of microbial tryptophan breakdown in the gut. In addition, skatole formation is not 
directly linked to testicular function so that high androstenone concentrations (>0.5 µg/g fat) 
were found in around 60% of the boars, but high skatole levels (>0.22  µg/g fat) only in 11% in a 
large EU-study (Bonneau et al., 2000). Nevertheless skatole accumulation is specifically 
favoured in males by testicular steroids, either by influencing gut mucosa turnover and thus 
supply of substrate for microbial processes (Raab et al, 1998) or by inhibiting liver metabolism 
by skatole (Zamaratskaia, 2004). Recent studies (Claus et al. 2003; Zamaratskaia, 2004) reveal 
that skatole accumulation can be easily inhibited by feeding strategies and also influenced by 
special housing conditions (Claus et al., 1996). 
 
Although intact boars have better growth performance and produce leaner carcass than castrates, 
surgical gonadectomy of male piglets is common practice in pig farming world-wide in order to 
prevent the occurrence of boar taint. In Switzerland, according to the Swiss Federal Ordinance on 
Animal Protection, surgical castration is allowed to be performed by the farmer within the first 
14 days of life without anaesthesia. This technique, however, is known to be associated with pain 
or stress independent of the animal's age. For that reason it is not surprising that during the last 
years, animal welfare organizations accused routine castration without anaesthesia as being a 
cruel and painful procedure. Influenced by animal welfare concern and some disadvantages of 
surgical castration (hemorrhage, infection) the Federal Veterinary Office has decided to support 
various projects which are all aimed at developing more acceptable and animal-friendly methods 
for practical application. Alternative techniques to prevent consumer reactions due to boar taint 
comprise the development of a chemical device ("chemical nose") to detect androstenone and 
other odorous steroids for the sorting out of tainted carcasses (Annor-Frempong et al., 1998). 
Furthermore, considerable research has also been conducted with various gaseous anaesthetic 
agents to reduce or eliminate the pain of surgical castration (Kohler et al., 1998). Another 
approach of improving meat quality and at the same time representing a method to influence 
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reproductive and behaviour characteristics of pigs is based on vaccination against gonadotropin-
releasing hormone (GnRH). This approach is the topic of this article. 
 
GnRH is a small peptide (decapeptide) originating in the hypothalamus acting on the anterior 
pituitary to induce the secretion of LH and FSH. These two gonadotropins act upon the gonads to 
stimulate testis growth and steroidogenesis. Testicular steroids, e.g. testosterone, are 
subsequently released into the circulation and transported to various tissues where they serve 
diverse functions including feedback regulation of GnRH, LH and FSH secretion, development 
of male sex characteristics as well as enhancement of muscle growth. Another steroid is 
androstenone (5α-androst-16-en-3-one) which is not androgenic but is stored in fat tissue and in 
part responsible for the unpleasant boar taint. Accordingly, immunization against GnRH will 
disrupt the hypothalamic-pituitary-gonad axis, thereby inhibiting testis growth and steroid 
synthesis which will finally also reduce the occurrence of boar odour. Inhibition of fertility by 
immunization against GnRH (immunocastration) has been successful in many animal species 
using various vaccine preparations (Carelli et al., 1985; Goubau et al., 1989; Adams et al., 1996; 
Dowsett et al., 1996; Janett et al., 2003). 
 
Because GnRH itself is too small to be immunogenic, it must be coupled with a carrier protein 
along with the use of an adjuvant. In pigs, GnRH-immunization to suppress offensive boar taint 
has first been reported by Falvo et al. (1986) and Caraty and Bonneau (1986) and later by other 
investigators (Bonneau et al., 1994; Oonk et al., 1998;  Beekman et al., 1999; Zeng et al., 2001). 
All authors used various conjugates, adjuvants and vaccination schedules. In farm animals, 
especially pigs, a GnRH-vaccine for commercial use must be economic and highly immunogenic 
to induce a sufficient titre of neutralizing anti-GnRH antibodies with only few injections needed. 
Furthermore, vaccination must be well-tolerable for the animal and most importantly, the 
components of the vaccine have to be safe and acceptable by the consumers. Recently, a vaccine 
has been developed in Australia that contains a modified form of GnRH with an aqueous 
adjuvant added. Vaccination is performed twice, 4 weeks apart, with the second injection given 5 
to 6 weeks before slaughter (Dunshea et al., 2001). 
 
The aim of the present study was to investigate the efficacy of Improvac® in two swine herds 
under practical conditions and to compare testes weight, androstenone concentration in fat, boar 
taint as well as growth performance and meat quality between immunized entire male pigs and 
surgically castrated male pigs. 
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2. Materials and methods 
2.1. Animals and experimental design 
For this study, a total of 533 male pigs (16% Swiss Landrace x Swiss Large White, 15% Swiss 
Large White x Swiss Landrace-Swiss Large White, 27% Swiss Large White x Swiss Large 
White, 27% Duroc x Swiss Large White, 15% Duroc x Swiss Landrace-Swiss Large White) from 
two different breeding farms located in the western part of Switzerland were used. After 
parturition, male piglets of each litter were randomly assigned to two groups with a total of 270 
animals for immunocastration (IC) and 263 animals for surgical castration (SC, controls) within 
the first 14 days of life. Litter effects were controlled by randomly assigning male piglets of each 
litter to both groups. The sample size was calculated such that a difference in proportion of 
tainted carcasses of at least 3 % could be detected on the 95 % confidence level with a power of 
80 %. Required sample size of each group was 256. 
After weaning at a weight of 25 kg, all littermates (intact males and barrows) were transported to 
two different farms (1 and 2) for the fattening period. Upon arrival in the new farms, all pigs 
were weighed and kept in pen-groups of 10 animals, independent of their sex. Pigs were fed three 
times a day a commercial feed together with whey in a ratio of 1 to 4. The diet ration included 
13.8 MJ metabolizable energy per kg dry matter (DM) and 18.5 % crude protein (CP) per kg 
MD. The animals had free access to water. All pigs were additionally weighed at days of 
vaccination and one day before slaughter. Thus, the daily growth rate for animals of both 
treatment groups could be calculated for the whole fattening period. 
 
2.2. Vaccine and immunization protocol 
For our experiments, active immunization against GnRH was performed using the vaccine 
Improvac® (CSL Ltd, Parkville, Victoria, Australia) containing a modified form of GnRH (200 
µg GnRH-protein conjugate/ml) in an aqueous adjuvant system. Pigs were vaccinated twice at an 
interval of at least 4 to 5 weeks with the second dose being given 4 to 6 weeks prior to slaughter. 
2 ml of Improvac® were injected subcutaneously behind the base of the ear using the original 
Improvac® vaccinator system. By this method no tissue irritation was observed. Expecting a 
body weight between 100 to 110 kg at slaughter, the two Improvac® doses in farm 1 were 
injected when pigs had a body weight of approximately 48 kg (average age of 16 weeks) and 77 
kg (average age of 21 weeks) and in farm 2 at 37 kg (average age of 14 weeks) and 64 kg 
(average age of 20 weeks), respectively. This difference in vaccination timing took into account 
different growth performances between the two farms. 
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2.3. Measurements at slaughter  
The animals were slaughtered at 100 to 110 kg bodyweight using low voltage electrical stunning. 
Reproductive organs were removed, trimmed and both testes with epididymes weighed. For 
comparison of testes weight, 77 intact boars of the same age were used as reference. Samples of 
fat were taken in the neck area and immediately deep-frozen (-20°C) for subsequent 
measurements of androstenone concentrations. Carcass weight was recorded 30 min. after 
slaughter (Bonneau et al., 1994). Lean meat expressed as % of carcass weight was measured 
using an ultrameter (CSB-ultra-meater, CSB-System). To determine olfactory perception of 
androstenone taint, the salivary glands of all pigs (IC, SC) were heated in a microwave oven 
(Micromat 700, AEG) on the highest temperature level (90°C) during 2 min., then cut and 
olfactorially assessed by two persons according to 5 androstenone-related taint-levels (0 = none, 
1 = negligible, 2 = little, 3 = modest, 4 = distinct). 
 
2.4. Androstenone analysis 
All fat samples were analysed by enzyme-immunoassay (EIA) as described by Claus et al., 1997. 
Tissue samples of about 0.5 to 1.0 g were heated for 4 min. at 200 watt in a microwave oven. The 
liquid fat (100 µl) was collected and mixed with methanol (900 µl, 50°C) on a vortex mixer, then 
cooled down to room temperature (about 20°C, for 20 min.) to obtain a supernatant containing 
androstenone. 100 µl of this supernatant were mixed with 0.9 ml assay buffer and 100 µl of that 
mixture were directly pipetted into the wells of antibody coated microtitre plates (Claus et al., 
1988). The sensitivity of the EIA was 0.04 µg androstenone per g fat. The mean intra- and inter-
assay coefficients of variation were 11.5 % and 13.9 %, respectively. 
 
2.5. Statistical analysis 
The issue of interest was the comparison of different outcome variables between the two 
treatments IC and SC (controls). Outcome variables were analysed using descriptive statistics. 
Where applicable, results are reported as mean values together with the 95 % confidence interval 
(95 % LCL; UPL). Androstenone concentrations <0.04 µg/g fat were replaced by the sensitivity 
threshold value of 0.04 (left-censoring). Univariate comparisons between treatments were 
conducted for the following continuous outcomes: androstenone concentration [µg/g fat], growth 
performance [kg/day], lean meat [% of carcass weight] and testes weight [g] using non 
parametric methods (Mann-Whitney U-test). Univariate comparisons between treatments were 
conducted for boar taint [scores 0 to 4] using Chi Square-test. Two-sided testing was used 
throughout. Multivariate analyses were conducted using analysis of variance for data of growth 
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performance and lean meat proportion. Outcome variables were normally distributed and did not 
require transformation. The factors “farm”, "litter" and “treatments” were included in the analysis 
as well as main interaction terms. P<0.05 was considered statistically significant. All statistical 
analyses were performed with the software package NCSS (Number Cruncher Statistical System 
2001, Kaysville, Utah). 
 
3. Results 
3.1. Androstenone concentrations in fat and boar taint 
In both farms, there was a balanced number of animals in the two groups (IC vs. SC). In Farm 1, 
132 SC and 135 IC animals were included, and in Farm 2, 131 SC and 135 IC animals were 
present. Androstenone levels between surgical castrates and immunocastrates were not 
significantly different (Table 1). The majority of immunocastrates were far below the 0.5 µg 
androstenone/g which is the  boar taint threshold level accepted by the European Union (EU, 
Meat Hygiene Ordinance, annex 1, chapter 4, 2.3.). When looking at individual concentrations, 
only 2 out of 270 immunocastrates had androstenone values above the EU-threshold (1.4 and 1.0 
µg/g fat, respectively).  
Results assessed by heating the salivary glands are presented in Table 1. More than 98 % SC and 
90 % IC had no androstenone-related odour and none of the animals tested had a distinct odour 
(level 4). Figure 1 demonstrates the relationship between various odour levels as assessed at 
slaughter and androstenone concentrations of each animal in both, the IC and SC groups. Both 
immunocastrated pigs with values > 0.5 µg/g fat had boar taint level 3, which is accepted for 
normal food consumption in Switzerland. 
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Table 1 
Concentrations and scores of androstenone, growth performance and lean meat in surgical 
castrated (SC) and immunocastrated pigs (IC) at slaughter. 
 
1 Mann-Whitney U-test, two-sided 
2 0 = none, 1 = negligible, 2 = little, 3 = modest, 4 = distinct  
3 Chi Square-test; percentages are given between brackets 
4 LCL = lower 95% confidence limit; UCL = upper 95% confidence limit; SD = standard 
deviation 
 
 
SC 
n=263 
IC 
n=270 
P  
Androstenone (µg/g fat) 
mean 
LCL 4 
UCL 4 
SD 4 
0.042  
0.041 
0.044 
0.013 
0.058  
0.044 
0.071 
0.109 
0.111 1 
Androstenone scores 0 – 4 2  n (%) 
0 
1 
2 
3 
4 
259 (98.5) 
4 (1.5) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
243 (90.0) 
18 (6.7) 
5 (1.8) 
4 (1.5) 
0 (0.0) 
0.000 3 
Growth performance (kg/day)  
mean 
LCL 
UCL 
SD 
0.817  
0.804 
0.830 
0.107 
0.827 
0.814 
0.840 
0.107 
0.353 1 
Lean meat (% of carcass weight) 
mean 
LCL 
UCL 
SD 
53.76  
53.53 
54.00 
1.919 
54.50  
54.26 
54.73 
1.960 
0.000 1 
 9
0
1
2
3
4
0.0 0.5 1.0 1.5  
 
 
Fig.1. Relationship between olfactorially assessed androstenone scores (0 - 4) and androstenone 
concentrations (µg/g fat; sensitivity threshold 0.04 µg/g) in surgical castrated (●, n=263) and 
immunocastrated pigs (x, n=270). Threshold value of 0.5 µg/g fat for androstenone (EU 
accepted) and ≤ 3 for androstenone score represent acceptance values. 
 
 
3.2. Growth performance, lean meat and testes weight 
The daily weight gain during the fattening period was not significantly different between both 
groups (Table 1). Surgical castrates had a slightly lower mean daily growth rate when compared 
to immunocastrates. This effect was also not statistically significant when tested by ANOVA 
where only the effect of litter was statistically significant (F=2.458, P<0.001) but not the effect of 
immunocastration (F=0.664, P=0.240) or farm (F=1.449, P=0.230). All interaction terms were 
not significant at the P=0.05 level. As shown in Table 1, average lean meat was significantly 
higher in immunocastrates when compared to surgical castrates. This was confirmed by ANOVA 
were the effect of immunocastration was highly significant (F=23.372, P<0.001). In the same 
analysis, the effect of litter was also significant (F=1.869, P<0.001), but not the effect of farm 
(F=0.206, P=0.650). Interactions involving type of castration were all not statistically significant 
indicating independence of the effect of immunocastration from the factors "farm" and "litter". 
Comparison of testes weight between 77 boars of the same age (24-26 weeks) as the 
immunocastrated pigs (n = 270) showed clear differences. Immunocastrates had a significantly 
Androstenone µg/g
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lower (P<0.001) mean testes weight (230.88 g (218.23; 243.52)) than control boars (761.89 g 
(722.77; 801.01)).  
 
4. Discussion 
Our study demonstrates that castration of male pigs can successfully be performed by active 
immunization against GnRH. This method therefore represents an effective and practical 
alternative to surgical castration. In Switzerland, the latter method is still allowed in piglets 
without anaesthesia during the first 14 days of life. As suggested by the vaccine manufacturer 
(CSL Ltd, Parkville, Victoria, Australia), Improvac® was given in two doses at an interval of 4 
weeks. The second dose which elicits an immune reaction with high antibody titres against 
GnRH should be given no later than 4 to 5 weeks prior to slaughter to allow any androstenone to 
be eliminated. Although this vaccination regimen has been shown to be quite effective (Dunshea 
et al., 2001), other strategies prolonging the interval between both vaccinations to 8 weeks 
(Meloen et al., 1994; Oonk et al., 1998; Turkstra et al., 2002) or vaccinating three times with 
intervals of 6 weeks (Metz et al., 2002) have also been reported. In our study the time of the first 
vaccination and the interval between the second vaccination and slaughter were shown to depend 
mainly on management and pig fattening traits in each farm.  
The immunization effect of Improvac® was best shown by androstenone concentrations in body 
fat, which fluctuated well below the threshold value of 0.5 µg/g fat, with a mean value of 0.058 
µg/g fat (0.044; 0.071) in immunocastrated pigs vs. 0.042 µg/g fat (0.041; 0.044) in surgically 
castrated pigs. Out of 270 immunocastrated pigs, only 2 animals being slaughtered 7.5 and 4.5 
weeks after the booster injection had values of 1.0 and 1.4 µg/g fat, respectively. These 
androstenone values were also reflected by high testicular weights of 705 g and 490 g, 
respectively and thus would have been easily detected at the slaughterline. Although the booster 
vaccinations in both animals were performed correctly in time, the reason for the differing results 
may most likely be the lack of immunological response known to be variable between 
individuals. 
Androstenone has been known for many years to be responsible for the unpleasant urine-like 
odour in boars (Claus, 1979). It is stored in fat tissue and is also intensively accumulated in 
salivary glands. Therefore, testing boar taint by heating the salivary glands in a microwave oven 
represents a very sensitive olfactorial method for androstenone detection. The classification of 
the odour, however, remains subjective and depends entirely on the person performing the test. In 
our study, testing the animals at slaughter was always performed by the same three persons (2 
female and 1 male) known to be very sensitive to adult boar fat odour. Figure 1 shows the strong 
relationship between measured androstenone concentrations in fat tissue and the olfactorial test 
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results when using 5 grades of sensation. Not surprisingly, both animals with androstenone 
values above 0.5 µg/g fat were also detected olfactorially as having boar taint, clearly 
demonstrating the reliability of the test. 
Growth performance in immunocastrated and surgical castrated pigs during the whole fattening 
period was not significantly different between both groups. In another study (Hennessy et al., 
2000; Cronin et al., 2003) it was shown that immunocastrated animals had a significant increased 
daily weight gain compared to boars, when only the last 4 weeks of the fattening period was 
considered. The better performance was most likely the result of prolonged anabolic influence 
before slaughter. In our study, immunocastrated and surgically castrated pigs were not kept 
separately during the whole fattening period.  
Comparing the meat quality between animals of both groups, the percent of lean meat was 
significantly higher in IC than in SC. This aspect should be considered in meat production 
industry as lean meat is accepted as a quality parameter with direct financial advantages for the 
farmer. Additional carcass quality characteristics such as intramuscular fat, colour of the meat 
and drip loss were also improved in immunocastrates compared to surgical castrates (Hennessy et 
al., 2000). 
From a clinical and practical point of view, the effect of Improvac® is clearly visible  in response 
to the second vaccination. During a period of 4 to 7 weeks duration, testes weight in IC decreased 
to an average of 230.88 g (30.3%) compared to normal testes weight in boars of 761.89 g 
(100%). Testes of a larger size weighing up to 500 g (n = 7) may produce more androstenone, but 
in our study, the concentration in fat tissue was nearly always well below 0.5 µg/g fat. Only 2 
animals with testes >500 g had androstenone concentrations above 1 µg/g fat with a positive 
olfactorial test at slaughter. Most importantly, however, the carcasses of both animals were still 
acceptable for consumption. As an objective method for boar taint characterization is still 
lacking, it would depend on the experience of meat inspectors to decide at which testicular size 
an olfactorial test would be indicated. The occurrence of testes weight differences at slaughter 
may either be the result of a prolonged interval between the booster injection and slaughter, or 
differences in testicular size already present at the time of the booster injection. Our results show 
that a time period of 4 to 7 weeks between the second vaccination and slaughter was not 
detrimental for the immunization effect. The question when testicular growth would start again 
after only one booster injection was not part of our study. Published results in sheep (Janett et al., 
2003) indicate that reversibility after vaccination may be individually determined and occurs at 
different time periods after vaccination.  
In summary, immunocastration with Improvac® was used in pigs for the first time in Switzerland. 
Vaccination twice 8 and 4 weeks before slaughter was demonstrated to be an effective and 
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practical method to suppress androstenone production. Vaccination is believed to be animal 
friendly, causing minimal stress and fear, however, this remains to be demonstrated by specific 
studies. Correct information of consumers and farmers must be given priority before considering 
the introduction of this method in Switzerland. 
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